Klin Farmakol Farm. 2024;38(2):83-87 | DOI: 10.36290/far.2024.014

Drug-induced psychotic syndrome

Jana Hroudová
1 Psychiatrická klinika, 1. lékařská fakulta, Univerzita Karlova a VFN v Praze
2 Farmakologický ústav, 1. lékařská fakulta, Univerzita Karlova a VFN v Praze
3 Oddělení klinické farmakologie a farmacie, VFN v Praze

Drug-induced psychotic disorder is related to symptoms such as hallucinations and delusions directly related to drug intake. They represent complications of patients' health and worsen their prognoses. The most frequently reported manifestations are psychoses with persecutory delusions and auditory hallucinations induced by drugs: corticosteroids, antiparkinsonian drugs, antimicrobials, analgesics, and drugs with anticholinergic effects. Treatment involves withdrawal of the suspected causative drug, in most cases, the condition is reversible. If discontinuation of this drug is not possible, administration of antipsychotics (mostly atypical) is appropriate, with careful consideration of risk factors, pharmacokinetic and pharmacodynamic interactions included. The aim of this article is to summarize the most common causes of drug induced psychotic states, their possible mechanism of origin, risk factors and possible options for their treatment.

Keywords: drug-induced psychotic syndrome, adverse drug effects.

Accepted: June 28, 2024; Published: July 15, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hroudová J. Drug-induced psychotic syndrome. Klin Farmakol Farm. 2024;38(2):83-87. doi: 10.36290/far.2024.014.
Download citation

References

  1. Sirois F, Steroid psychosis: a review. Gen Hosp Psychiatry. 2003;25(1):27-33. Go to original source... Go to PubMed...
  2. Niebrzydowska A, Grabowski J. Medication-induced Psychotic Disorder. A Review of Selected Drugs Side Effects. Psychiatr Danub. 2022;34(1):11-18. Go to original source... Go to PubMed...
  3. Warrington TP and Bostwick JM, Psychiatric adverse effects of corticosteroids. Mayo Clin Proc. 2006;81(10):1361-1367. Go to original source... Go to PubMed...
  4. Avila-Funes JA, et al. Association between high serum estradiol levels and delirium among hospitalized elderly women. Rev Invest Clin. 2015; 67(1):20-24.
  5. Trenton AJ, Currier GW. Behavioural manifestations of anabolic steroid use. CNS Drugs. 2005;19(7):571-595. Go to original source... Go to PubMed...
  6. Beaulieu-Boire I, Lang AE. Behavioral effects of levodopa. Mov Disord. 2015;30(1):90-102. Go to original source... Go to PubMed...
  7. Parkinson study group, Low-dose clozapine for the treat­ment of drug-induced psychosis in Parkinson's disease. N Engl J Med. 1999;340(10):757-763. Go to original source... Go to PubMed...
  8. Taddei RN, et al. Management of Psychosis in Parkinson's Disease: Emphasizing Clinical Subtypes and Pathophysiological Mechanisms of the Condition. Parkinsons Dis. 2017; 2017:3256542. Go to original source... Go to PubMed...
  9. Usui C, et al. Improvements in both psychosis and motor signs in Parkinson's disease, and changes in regional cerebral blood flow after electroconvulsive therapy. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(7):1704-1708. Go to original source... Go to PubMed...
  10. Lombardo M, et al. Treatment of Acute Delirium in a Patient with Parkinson's Disease by Transfer to the Intensive Care Unit and Administration of Dexmedetomidine, in J Mov Disord. 2020;159-162. Go to original source... Go to PubMed...
  11. Callegari E, et al. A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder. Br J Clin Pharmacol. 2011;72(2):235-246. Go to original source... Go to PubMed...
  12. Preda A, et al. Antidepressant-associated mania and psychosis resulting in psychiatric admissions. J Clin Psychiatry. 2001;62(1):30-33. Go to original source... Go to PubMed...
  13. Fortunati F, et al. Plasma catecholamine metabolites in antidepressant-exacerbated mania and psychosis. J Affect Disord. 2002;68(2-3):331-334. Go to original source... Go to PubMed...
  14. Sivanesan E, Gitlin MC, Candiotti KA. Opioid-induced Hallucinations: A Review of the Literature, Pathophysiology, Diagnosis, and Treatment. Anesth Analg. 2016;123(4):836-843. Go to original source... Go to PubMed...
  15. Hoppmann RA, Peden JG, Ober SK. Central Nervous System Side Effects of Nonsteroidal Anti-inflammatory Drugs: Aseptic Meningitis, Psychosis, and Cognitive Dysfunction. Archives of Internal Medicine. 1991;151(7):1309-1313. Go to original source...
  16. Risser A, et al. NSAID prescribing precautions. Am Fam Physician. 2009;80(12):1371-1378.
  17. Bangert MK, Hasbun R. Neurological and Psychiatric Adverse Effects of Antimicrobials. CNS Drugs. 2019;33(8):727-753. Go to original source... Go to PubMed...
  18. Bhattacharyya S, et al. Antibiotic-associated encephalopathy. Neurology. 2016; 86(10):963-971. Go to original source... Go to PubMed...
  19. Teng C, Frei CR. Delirium Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS). Drugs Real World Outcomes. 2022; 9(1):23-29. Go to original source... Go to PubMed...
  20. Tomé AM, Filipe A. Quinolones: review of psychiatric and neurological adverse reactions. Drug Saf. 2011;34(6):465-488. Go to original source... Go to PubMed...
  21. Graham JH, Maher JR, Robinson SE. The effect of cocaine and other local anesthetics on central dopaminergic neurotransmission. J Pharmacol Exp Ther. 1995;274(2):707-717. Go to original source...
  22. Prasad R, Garg R, Verma SK, Isoniazid- and ethambutol-induced psychosis, in Ann Thorac Med. 2008;149-151. Go to original source... Go to PubMed...
  23. Pascual A, et al. Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. Clin Infect Dis. 2008;46(2):201-211. Go to original source... Go to PubMed...
  24. Wotton CJ, Goldacre MJ. Coexistence of schizophrenia and epilepsy: record-linkage studies. Epilepsia. 2012; 53(4):e71-74. Go to original source... Go to PubMed...
  25. Agrawal N, Mula M. Treatment of psychoses in patients with epilepsy: an update. Ther Adv Psychopharmacol. 2019; 9:2045125319862968. Go to original source... Go to PubMed...
  26. Sioka C, Kyritsis APOD. Central and peripheral nervous system toxicity of common chemotherapeutic agents. Cancer Chemother Pharmacol. 2009;63(5):761-767. Go to original source... Go to PubMed...
  27. Scatchard K, Ming Lee S. 16 - Neurotoxicity of Chemotherapy, in Blue Books of Neurology, Rees J and Wen PY, Editors. 2010;352-371. Go to original source...
  28. Carrillo de Albornoz Calahorro CM, et al. Successful treat­ment of psychosis induced by interferon alpha and ribavirin with paliperidone: first case reported. Gen Psychiatr. 2019;32(4):e100075. Go to original source... Go to PubMed...




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.